We are live on ! Find out more
TNXP icon

Tonix Pharmaceuticals
TNXP

15 hedge funds and large institutions have $85.3M invested in Tonix Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

64% more capital invested

Capital invested by funds: $52M → $85.3M (+$33.3M)

60% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 5

25% more funds holding

Funds holding: 12 → 15 (+3)

0% more ownership

Funds ownership: 0% → 0% (+0%)

Holders
15
Holders Change
+3
Holders Change %
+25%
% of All Funds
0.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
4
Reduced
2
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$21.3M
2
State Street
State Street
Massachusetts
+$5.88M
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$2.94M
4
Norges Bank
Norges Bank
Norway
+$2.94M
5
Northern Trust
Northern Trust
Illinois
+$2.94M

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$1.47M
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$1.01M
3
Citadel Advisors
Citadel Advisors
Florida
-$776K
4
ECM
ExodusPoint Capital Management
New York
-$735K
5
Millennium Management
Millennium Management
New York
-$735K
Name Holding Trade Value Shares
Change 		Change in
Stake
Prudential Financial
51
Prudential Financial
New Jersey
$23K – – –
EH
52
Equitable Holdings
New York
$22K – – –
SGI
53
Summit Global Investments
Utah
$22K – – –
Wells Fargo
54
Wells Fargo
California
$21K – – –
X
55
Xponance
Pennsylvania
$20K – – –
Citigroup
56
Citigroup
New York
$17K – – –
PWM
57
Purus Wealth Management
California
$17K – – –
SWM
58
Spire Wealth Management
Virginia
$17K – – –
CIBC Asset Management
59
CIBC Asset Management
Ontario, Canada
$14K – – –
SG Americas Securities
60
SG Americas Securities
New York
$14K – – –
CAN
61
Cetera Advisor Networks
California
$13K – – –
Jane Street
62
Jane Street
New York
$13K – – –
ZIG
63
Zuckerman Investment Group
Illinois
$13K – – –
Mackenzie Financial
64
Mackenzie Financial
Ontario, Canada
$12K – – –
LCC
65
Lincoln Capital Corp
Rhode Island
$11K – – –
SAF
66
Smith Anglin Financial
Texas
$11K – – –
UBS Group
67
UBS Group
Switzerland
$9K – – –
Osaic Holdings
68
Osaic Holdings
Arizona
$7K – – –
HI
69
Harbour Investments
Wisconsin
$6K – – –
PAM
70
Panagora Asset Management
Massachusetts
$6K – – –
FDCDDQ
71
Federation des caisses Desjardins du Quebec
Quebec, Canada
$5.55K – – –
GI
72
Gradient Investments
Minnesota
$2K – – –
BWL
73
Bogart Wealth LLC
Virginia
$1K – – –
NSIM
74
North Star Investment Management
Illinois
$1K – – –
PWM
75
Prentice Wealth Management
New York
$1K – – –
1 2
3
4

TNXP Hedge Fund Activity: Q2 2021 in Review

15 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Tonix Pharmaceuticals (TNXP) for Q2 2021, worth a combined $85.3M — up 64% from $52M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new TNXP positions and 5 closed out — a net gain of 3 holders — while 4 added to existing stakes and 2 trimmed.

The largest buyer was BlackRock, adding an estimated $21.3M. The largest seller was Renaissance Technologies, cutting an estimated $1.47M.

  • 15 institutional investors held Tonix Pharmaceuticals (TNXP) as of Q2 2021, up from 12 in Q1 2021.
  • Funds reported $85.3M of Tonix Pharmaceuticals stock for Q2 2021, up 64% quarter-over-quarter.
  • 8 funds opened new Tonix Pharmaceuticals positions in Q2 2021 and 5 closed out, a net change of +3 holders.
  • The largest Tonix Pharmaceuticals buyer in Q2 2021 was BlackRock, an estimated $21.3M added.
  • The largest Tonix Pharmaceuticals seller in Q2 2021 was Renaissance Technologies, an estimated $1.47M sold.

Based on aggregated 13F filings for Q2 2021.